Liquidia Corp. (LQDA)
70.28
+1.66
(+2.41%)
USD |
NASDAQ |
Aug 24, 16:00
70.28
0.00 (0.00%)
After-Hours: 19:20
Liquidia 1 Year Total Returns (Daily) : 151.4% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 151.4% |
| August 20, 2026 | 159.8% |
| August 19, 2026 | 177.9% |
| August 18, 2026 | 168.1% |
| August 17, 2026 | 199.4% |
| August 14, 2026 | 185.3% |
| August 13, 2026 | 186.1% |
| August 12, 2026 | 226.9% |
| August 11, 2026 | 315.3% |
| August 10, 2026 | 345.1% |
| August 07, 2026 | 369.7% |
| August 06, 2026 | 340.3% |
| August 05, 2026 | 344.0% |
| August 04, 2026 | 353.7% |
| August 03, 2026 | 374.3% |
| July 31, 2026 | 350.0% |
| July 30, 2026 | 354.2% |
| July 29, 2026 | 350.8% |
| July 28, 2026 | 338.0% |
| July 27, 2026 | 330.7% |
| July 24, 2026 | 359.4% |
| July 23, 2026 | 401.6% |
| July 22, 2026 | 424.3% |
| July 21, 2026 | 435.7% |
| July 20, 2026 | 430.1% |
| Date | Value |
|---|---|
| July 17, 2026 | 447.5% |
| July 16, 2026 | 430.4% |
| July 15, 2026 | 435.8% |
| July 14, 2026 | 428.2% |
| July 13, 2026 | 405.4% |
| July 10, 2026 | 450.7% |
| July 09, 2026 | 504.2% |
| July 08, 2026 | 521.8% |
| July 07, 2026 | 552.4% |
| July 06, 2026 | 549.8% |
| July 02, 2026 | 554.5% |
| July 01, 2026 | 561.0% |
| June 30, 2026 | 539.9% |
| June 29, 2026 | 473.4% |
| June 26, 2026 | 509.3% |
| June 25, 2026 | 465.6% |
| June 24, 2026 | 448.2% |
| June 23, 2026 | 458.4% |
| June 22, 2026 | 473.2% |
| June 18, 2026 | 421.0% |
| June 17, 2026 | 405.2% |
| June 16, 2026 | 382.7% |
| June 15, 2026 | 409.2% |
| June 12, 2026 | 392.9% |
| June 11, 2026 | 406.9% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Indivior Pharmaceuticals, Inc. | 53.31% |
| Harmony Biosciences Holdings, Inc. | 2.31% |
| Johnson & Johnson | 54.80% |
| Amneal Pharmaceuticals, Inc. | 87.93% |
| Corcept Therapeutics, Inc. | 72.23% |